Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (64)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- Renal perfusion depends on large-artery inflow
- Ostial plaques: Important morphologic details
- Angiotensin II is the early vasoconstrictor effector
- The ischemic kidney becomes smaller
- Two kidneys in unilateral renovascular hypertension
- Large-vessel stenosis and microvascular narrowing act at different levels
- Recognizing revascularizable disease matters
- Primary source and interpretation boundaries
Slide index & full transcript (64 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Atherosclerotic
Ischemic Renal Disease
Renal vascular pathology • Mechanisms, morphology, clinical correlation
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning objectives
Differentiate renovascular hypertension from ischemic renal insufficiency.
Explain how atherosclerotic renal artery stenosis affects renal blood flow.
Identify gross and microscopic consequences of chronic hypoperfusion.
Distinguish large-artery stenosis from other renal vascular lesions.
Interpret two-kidney physiology and relevant diagnostic principles.
Slide 3 · Renal perfusion depends on large-artery inflow
AORTA
Renal artery
Renal artery
Narrowing at the renal artery origin can limit downstream perfusion.
Slide 4 · Definition and scope
Chronic renal hypoperfusion caused by atherosclerotic narrowing of the renal arteries
The clinical expression depends on lesion distribution, severity, duration, and preexisting parenchymal injury.
Slide 5 · The central disease pathway
Atherosclerotic plaque
Typically near the renal artery origin
Narrowed lumen
Less pressure and flow distal to the lesion
Chronic renal ischemia
Sustained reduced perfusion
Renal insufficiency
Progressive loss of functional renal tissue
The same lesion can also initiate renovascular hypertension.
Slide 6 · Two overlapping presentations
Pattern
Dominant physiologic effect
Teaching consequence
Unilateral stenosis
Renin release from an ischemic kidney
Secondary renovascular hypertension
Bilateral disease
Perfusion compromise in both kidneys
Renal insufficiency; Hypertension may be absent
Coexisting lesions
Vascular and parenchymal processes overlap
Mixed clinical and morphologic phenotype
Slide 7 · An important diagnostic paradox
Ischemic renal insufficiency may occur without hypertension
Bilateral atherosclerotic renal artery disease can be associated with renal dysfunction even when hypertension is absent.
Slide 8 · The characteristic clinical setting
Atherosclerotic narrowing is especially relevant in older individuals.
The parent renal artery stenosis section describes increasing frequency with age and diabetes.
Renal function may deteriorate gradually when both kidneys have impaired inflow.
Hypertension is neither required nor sufficient to establish ischemic renal disease.
Slide 9 · Atherosclerosis is the principal cause of renal artery stenosis
The typical plaque is located near the arterial origin
The Robbins source reports atherosclerotic narrowing at the renal artery origin as the most common cause of renal artery stenosis (approximately 70%).
Slide 10 · Atherosclerotic lesions often occupy the renal artery origin
Schematic arterial cross-section
Plaque site
Near the aortic origin of the renal artery
Lumen
Narrowing reduces the perfusion pathway
Superimposed change
Thrombosis may complicate the plaque
Slide 11 · Ostial plaques: Important morphologic details
The lesion often narrows the proximal artery at its origin from the aorta.
The plaque as usually concentric.
Thrombosis may be superimposed on the atheroma.
Proximal inflow obstruction can affect the entire downstream kidney.
Slide 12 · Atheroma plus thrombosis can intensify obstruction
Proximal plaque
Fixed atheromatous narrowing
Superimposed thrombus
Additional reduction in luminal area
Lower distal perfusion
Greater ischemic burden
Parenchymal injury
Functional or structural consequences
Thrombosis is described as a possible superimposed change, not a universal event.
Slide 13 · Atherosclerosis versus fibromuscular dysplasia
Feature
Atherosclerosis
Fibromuscular dysplasia
Age setting
Typically older patients
Typically younger adults
Sex association
More frequent in males
More frequent in females
Lesion
Atheromatous plaque near origin
Fibrous/fibromuscular arterial thickening
Distribution
Often proximal ostial lesion
Can involve intima, media or adventitia
Slide 14 · Stenosis creates a perfusion-pressure problem
Anatomic narrowing
Higher resistance to flow
Reduced downstream pressure
Signals to ischemic kidney
Functional response
Renin–angiotensin system activation
Systemic effect
Increased blood pressure
Slide 15 · Systemic blood pressure does not equal intrarenal perfusion
An elevated systemic pressure can coexist with a poorly perfused kidney
A proximal arterial lesion can separate pressure in the aorta from pressure experienced by the downstream renal circulation.
Slide 16 · Unilateral stenosis: Asymmetrical perfusion and pressure effects
AORTA
Reduced arterial inflow
Relatively preserved inflow
Renin from the ischemic kidney can drive systemic hypertension.
Slide 17 · The ischemic kidney activates renin secretion
Reduced renal perfusion
Signal at juxtaglomerular apparatus
Renin release
Endocrine response to ischemia
Angiotensin II generation
Vasoconstrictor pathway
Systemic hypertension
Raised vascular resistance
Slide 18 · Why renin matters in renovascular hypertension
Increased renin production by the ischemic kidney as the principal initiating mechanism.
Renin secretion activates the angiotensin pathway.
Angiotensin II is a potent vasoconstrictor.
The pressure response depends on the extent of arterial narrowing.
Slide 19 · Renin–angiotensin sequence
Renal ischemia
Juxtaglomerular renin secretion
RAAS activation
Downstream hormonal cascade
Angiotensin II
Systemic arteriolar constriction
Hypertension
Rise in arterial pressure
Slide 20 · Angiotensin II is the early vasoconstrictor effector
Arterial constriction raises systemic vascular resistance
Angiotensin II in the initial elevation of blood pressure following renal artery constriction.
Slide 21 · Sodium retention contributes to sustained hypertension
Renin–angiotensin activation initiates the pressure rise.
Sodium retention as a contributor to the maintenance of hypertension.
Long-standing hypertension need not remain dependent on one isolated signal.
Mechanisms of pressure maintenance should be distinguished from the stenotic lesion itself.
Slide 22 · Goldblatt physiology links stenosis to blood pressure
Renal artery constriction
Experimental change in inflow
Ischemic kidney
Release of renin
Angiotensin II
Hormone-mediated vasoconstriction
Blood pressure rise
Effect scales with narrowing
Slide 23 · The stenosis–hypertension relationship is not purely structural
A vascular lesion initiates endocrine and hemodynamic adaptation
Renin–angiotensin activation as an initiating mechanism, with other factors potentially maintaining hypertension.
Slide 24 · Bilateral stenosis: Diminished inflow to both kidneys
AORTA
Reduced arterial inflow
Reduced arterial inflow
Chronic ischemia can impair total renal function.
Slide 25 · Bilateral stenosis threatens total functional renal mass
Both renal arteries affected
Inflow to both kidneys impaired
Sustained hypoperfusion
Chronic parenchymal ischemia
Atrophy and scarring
Reduced functional nephron mass
Renal insufficiency
Declining aggregate function
Slide 26 · Why hypertension can be absent in bilateral disease
Renal insufficiency is a perfusion-related outcome, not a diagnostic synonym for hypertension
Robbins explicitly separates chronic ischemic renal insufficiency from the obligatory presence of hypertension.
Slide 27 · Persistent ischemia produces chronic renal injury
Impaired arterial inflow
Reduced perfusion reserve
Ongoing parenchymal stress
Tubular and glomerular damage
Atrophy and fibrosis
Loss and replacement of renal tissue
Smaller kidney
Reduced mass and function
Slide 28 · The ischemic kidney becomes smaller
The ischemic kidney as reduced in size.
Diffuse atrophy reflects loss of viable renal parenchyma.
Tubular atrophy and interstitial fibrosis are central correlates.
Kidney size alone cannot identify the precise cause of chronic injury.
Slide 29 · Renal atrophy is a tissue consequence, not a plaque image
A small kidney demonstrates chronic loss of parenchyma
Direct demonstration of the arterial narrowing and evaluation of competing causes are distinct diagnostic tasks.
Slide 30 · Glomerular crowding reflects loss of surrounding parenchyma
Illustration only — not tissue microscopy
Atrophic ischemic kidney
Reduced tubular volume
Glomeruli appear closer together
Slide 31 · Tubular atrophy is a major component of chronic ischemia
Illustration only — not tissue microscopy
Sustained reduced flow
Tubular epithelial loss and shrinkage
Reduced tubular profiles and function
Slide 32 · Interstitial fibrosis records chronic parenchymal damage
Illustration only — not tissue microscopy
Prolonged vascular insufficiency
Tubulointerstitial injury
Fibrous replacement of lost tissue
Slide 33 · Focal inflammatory infiltrates may accompany chronic injury
Illustration only — not tissue microscopy
Chronic ischemic injury
Interstitial response
Focal inflammatory infiltrates
Slide 34 · Arterioles downstream may be relatively protected
The stenotic kidney receives less of the systemic pressure load.
Its arterioles commonly show only mild arteriolosclerosis.
This can coexist with pronounced parenchymal atrophy.
Severity of pressure-related arteriolar change need not parallel ischemic tissue loss.
Slide 35 · The contralateral kidney experiences a different hemodynamic environment
The well-perfused kidney may show more severe arteriolosclerosis
The severity depends on the hypertension experienced by the contralateral kidney.
Slide 36 · Two kidneys in unilateral renovascular hypertension
Tissue feature
Stenotic kidney
Contralateral kidney
Pressure exposure
Reduced by upstream stenosis
Exposed to systemic hypertension
Size and atrophy
Often small and diffusely atrophic
Not necessarily ischemic from this lesion
Arteriolosclerosis
May be comparatively mild
May be more severe
Dominant driver
Hypoperfusion
Pressure-related vascular injury
Slide 37 · The morphologic triad is not etiologically specific
Glomerular changes + tubular atrophy + interstitial fibrosis
Atherosclerotic ischemic disease must be interpreted together with arterial disease and the distribution of renal injury.
Slide 38 · Nephrosclerosis overlaps with chronic ischemic renal injury
Nephrosclerosis includes glomerulosclerosis, tubulointerstitial scarring, arteriosclerosis and arteriolosclerosis.
Hypertension and age are important associations, but not exclusive explanations.
Small-vessel narrowing produces focal renal ischemia.
Large-artery atherosclerotic stenosis represents a different anatomic level of perfusion limitation.
Slide 39 · Nephrosclerosis can amplify parenchymal ischemia
Intimal and medial thickening
Narrowing of small arteries
Arteriolar hyalinization
Further luminal reduction
Focal hypoperfusion
Ischemic nephron injury
Scarring
Glomerulosclerosis and tubular loss
Slide 40 · Hyaline arteriolosclerosis acts within the microcirculation
Protein-rich hyaline material thickens arteriolar walls
The narrowed lumens contribute to focal parenchymal ischemia. This is distinct from an ostial renal artery plaque.
Slide 41 · Fibroelastic hyperplasia affects intrarenal arteries
Interlobular and arcuate arteries can show medial hypertrophy.
Replication of the internal elastic lamina and intimal tissue accumulation narrow lumens.
These changes increase with age and hypertension.
Unlike renal artery ostial atheroma, this is an intrarenal vessel-wall process.
Slide 42 · From microvascular hypoperfusion to glomerular loss
Small-vessel narrowing
Focal reduction in perfusion
Glomerular ischemia
Capillary tuft and GBM changes
Sclerosis
Collagen and nephron loss
Tubular dropout
Regional interstitial scar
Slide 43 · Chronic atrophy versus renal infarction
Feature
Chronic ischemic atrophy
Renal infarction
Time course
Persistent or progressive hypoperfusion
Abrupt vascular occlusion
Morphology
Diffuse or patchy atrophy and fibrosis
Coagulative necrosis and later scar
Gross pattern
Renal shrinkage
Classically wedge-shaped pale lesion
Clinical link
Progressive renal insufficiency
May be painful or clinically silent
Slide 44 · Large-vessel stenosis and microvascular narrowing act at different levels
Renal artery
Ostial atheromatous plaque
Small artery
Fibroelastic intimal changes
Arteriole
Wall hyalinization
Slide 45 · Clinical expression is often nonspecific
Older patients with renal artery stenosis may resemble those with essential hypertension.
Atherosclerotic bilateral disease may present primarily as renal insufficiency.
Symptoms and examination alone do not define arterial anatomy.
Diagnostic interpretation must connect vascular findings with renal functional impairment.
Slide 46 · No classic symptom reliably establishes renal artery stenosis
Clinical suspicion and anatomic localization are separate steps
That distinctive clinical features are few, even in renovascular hypertension.
Slide 47 · A renal bruit is a possible clue, not proof
A bruit may occasionally be heard over an affected kidney.
Auscultation does not locate or grade an arterial lesion.
Absence of a bruit is not an exclusion criterion.
A bruit belongs in a broader evaluation rather than functioning as a stand-alone diagnosis.
Slide 48 · Renin testing reflects physiology, not arterial anatomy
Renovascular hypertension is initiated by renin from the ischemic kidney.
Elevated plasma or renal-vein renin as potentially helpful.
Renin values do not, by themselves, demonstrate the location of stenosis.
Endocrine and structural assessments address different questions.
Slide 49 · Response to angiotensin blockade supports pathway involvement
Functional response is not equivalent to lesion localization
Blood pressure reduction with medications that block angiotensin II activity in renovascular hypertension; This slide is mechanistic, not prescribing advice.
Slide 50 · Anatomic and functional evaluation answer different questions
Morphology suggests the effect of chronic vascular insufficiency on parenchyma.
Renal scans and intravenous pyelography are mentioned clinical discussion.
These tests are described as diagnostic aids, not as histologic evidence.
The cited source uses arteriography for definitive anatomic localization.
Slide 51 · Arteriography localizes a stenotic arterial lesion
A demonstrable narrowing establishes anatomy; Attribution of renal dysfunction requires interpretation
Arteriography as necessary to localize stenosis in its renal artery stenosis discussion and commonly used for bilateral disease.
Slide 52 · Clinicopathologic diagnostic synthesis
Identify phenotype
Hypertension, renal insufficiency or both
Assess parenchyma
Atrophy and chronic scarring
Evaluate vessels
Atherosclerotic renal artery narrowing
Integrate causality
Does vascular lesion explain the renal findings?
Do not assume every detected stenosis is causative.
Slide 53 · Recognizing revascularizable disease matters
Surgical revascularization can prevent further loss of renal function in selected ischemic disease.
This is a conditional statement of potential benefit, not a universal indication.
Established parenchymal scarring and competing injury may limit functional recovery.
Contemporary procedural decisions require evidence and guidelines beyond this textbook excerpt.
Slide 54 · Vascular correction and parenchymal recovery are not synonymous
Restoring arterial inflow does not automatically reverse established renal scarring
This is a pathophysiologic inference from the parent morphology section; Robbins gives no universal recovery guarantee for ischemic renal disease.
Slide 55 · Differential: Atherosclerotic stenosis and fibromuscular dysplasia
Axis
Atherosclerotic disease
Fibromuscular dysplasia
Typical context
Older; Age and diabetes association
Younger; Female predominance
Wall pathology
Atheromatous plaque
Fibrous/fibromuscular thickening
Usual mechanism
Large-artery inflow limitation
Large-artery inflow limitation
Interpretation
Can impair bilateral renal function
More often taught as a cause of renovascular HTN
Slide 56 · Differential: Fixed stenosis and atheroembolic disease
Axis
Atherosclerotic ischemic disease
Atheroembolic renal disease
Vascular process
Fixed renal artery narrowing
Plaque material embolizes distally
Anatomic site
Proximal renal artery
Intrarenal arterial branches
Histologic clue
Chronic parenchymal atrophy
Cholesterol-cleft emboli
Clinical setting
Chronic ischemic insufficiency
Often after arterial instrumentation
Slide 57 · Differential: Large-artery disease and thrombotic microangiopathy
Axis
Atherosclerotic ischemia
TMA
Principal level
Renal artery inflow lesion
Capillaries and arterioles
Characteristic injury
Chronic hypoperfusion and atrophy
Microthrombi and endothelial injury
Associated pattern
Renovascular HTN or renal insufficiency
Hemolysis, thrombocytopenia, ischemia
Specific mechanism
Atheromatous narrowing
Diverse toxin/complement/platelet pathways
Slide 58 · Differential: Chronic ischemia and acute infarction
Axis
Chronic atherosclerotic hypoperfusion
Renal infarct
Vascular event
Sustained stenosis
Usually embolic occlusion
Parenchymal lesion
Atrophy, fibrosis and renal shrinkage
Wedge-shaped ischemic coagulative necrosis
Clinical course
Can be insidious
May cause costovertebral pain and hematuria
Pathologic point
Viable but chronically injured nephrons
Established necrosis and subsequent scarring
Slide 59 · Case 1: Asymmetric renovascular hypertension
Clinical vignette
An older patient with hypertension has severe proximal narrowing of one renal artery. The affected kidney is smaller; Its intrarenal arteriolar disease is comparatively mild.
Interpret
How can severe hypertension coexist with relatively little arteriolosclerosis in the affected kidney?
Explanation
Upstream stenosis reduces pressure exposure in that kidney; Renin release raises systemic blood pressure, affecting the contralateral kidney.
Slide 60 · Case 2: Renal insufficiency without hypertension
Clinical vignette
An older individual has slowly declining renal function and bilateral atherosclerotic renal artery disease, but does not have sustained hypertension.
Interpret
Does the absence of hypertension rule out ischemic renal disease? Which mechanism is most relevant?
Explanation
No. Bilateral compromised inflow can produce chronic renal ischemia and insufficiency even without hypertension.
Slide 61 · Case 3: Contrasting renal vascular lesions
Clinical vignette
A patient has unilateral renal artery narrowing, a small ischemic kidney, and pronounced arteriolosclerosis in the opposite kidney.
Interpret
Which lesion is attributed mainly to hypoperfusion, and which to systemic pressure?
Explanation
Ischemic atrophy is expected in the stenotic kidney; More marked pressure-related arteriolosclerosis may develop contralaterally.
Slide 62 · Synthesis: Three useful vascular patterns
Pattern
Primary lesion
Dominant pathology
Renal artery atheroma
Proximal large-vessel narrowing
Renin-driven hypertension or chronic ischemia
Hypertensive nephrosclerosis
Arteries and arterioles
Patchy ischemic atrophy and glomerulosclerosis
Atheroembolism
Distal arterial plaque fragments
Cholesterol-cleft emboli; Variable AKI
Slide 63 · Final clinicopathologic synthesis
Atherosclerotic renal artery narrowing often occurs near the arterial origin.
Unilateral disease may produce renin-mediated hypertension.
Bilateral disease can cause chronic renal insufficiency even without hypertension.
Chronic ischemia produces renal shrinkage, tubular atrophy and interstitial fibrosis.
Distinguish fixed stenosis from nephrosclerosis, atheroembolism and infarction.
Slide 64 · Primary source and interpretation boundaries
Robbins, Cotran & Kumar: Pathologic Basis of Disease
11th edition (2026) • Chapter 20: The Kidney
Atherosclerotic Ischemic Renal Disease — p. 855
Parent sections: Nephrosclerosis (pp. 851–852) and Renal Artery Stenosis (pp. 852–853).
Adjacent differential context: Atheroembolic Renal Disease and Renal Infarcts.
No original textbook histology images reproduced; all schematics are native editable illustrations.